Interval training program for patients with chronic heart failure
Effects of Progressive Interval Training on V02 Max in Chronic Heart Failure Patients
NA · University Hospital, Montpellier · NCT03955029
This study tests whether a new type of interval training can help older patients with chronic heart failure feel better and improve their ability to exercise compared to regular training.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University Hospital, Montpellier (other) |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT03955029 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of an interval training exercise program on patients with chronic heart failure (CHF). It aims to compare the outcomes of progressive interval training versus conventional interval training in improving patients' functional capacity and overall health. The study includes patients aged 40 and older with systolic heart failure and a functional capacity of 6 METs or less, who are undergoing cardiac rehabilitation. The trial will assess improvements in exercise capacity, quality of life, and potential reductions in hospitalization rates.
Who should consider this trial
Good fit: Ideal candidates are adults aged 40 and older with chronic systolic heart failure and limited functional capacity.
Not a fit: Patients with contraindications to rehabilitation or those unable to perform the required exercises may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly enhance the physical capacity and quality of life for patients suffering from chronic heart failure.
How similar studies have performed: Previous studies have shown that interval training can improve exercise capacity in heart failure patients, suggesting a promising approach for this population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with chronic systolic heart failure (LVEF \<40%) * men or women * 40 years patients or older * Patients admitted on cardiac rehabilitative medical prescription * Patients with a functional capacity of 6 Mets or less * Patients having given their free and informed consent to the study. Exclusion Criteria: * Contraindication to rehabilitation, * Refusal of the patient to participation in the study * impaired comprehension * inability to perform the cyclometer * participation in another therapeutic protocol simultaneously
Where this trial is running
Montpellier
- CHU Montpellier — Montpellier, France (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Heart Failure